Physician profile
Robert Guyette
NPI 1346300415
$869.91
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $52.06 · 2021: $133 · 2022: $94.78 · 2023: $241 · 2024: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40.00 · Gift: $34.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40.00 |
| Gift | $34.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $562.11 | 2019-2023 | Nobelactive |
| Depuy Synthes Sales INC. | $108.59 | 2020-2021 | |
| Straumann USA LLC | $58.60 | 2023-2024 | |
| Medical Device Business Services, INC. | $43.52 | 2021 | |
| Abbvie INC. | $40.00 | 2024 | |
| Revance Therapeutics, INC. | $36.30 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $20.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Guyette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.